GLG News by Physicians who Implant Intraocular Lenses

In this exciting study, they report that phacoemulsification and IOL implantation significantly decreases intraocular pressure in ocular hypertensive eyes in elder patients.  The ocular hypotensive effect may prevent glaucoma and be another option in glaucoma managment.

The current paradigm of Dry Eye disease revolves around inflammation as a key and essential component in its development and progression. Many current and developing regimens (artificial tears, secretagogues such as Ecabet sodium and diquafosol and 15-HETE, mucomimetics such as Milicin, etc...) do...

For a company that has had its share of rejections and problems with the approval of a phakic IOL (ICL Visian)  that it tried to have enter the US market almost a decade ago, things are not improving much for Staar.  The company recently reported that despite its request over one year ago...

Mutifocal iols are currently used to try to correct distance and near vision.  While patients are often pleased by their improved near vision without glasses, many complain of poor optical quality for distance vision.  Due to great out of pocket costs and poor quality of vision under some...

These cases may just be an isolated incident and the report of one or two cases clearly creates attention to the infection and awareness for further cases. In the over 11 years since laser vision correction has been approved in the USA we have not seen much incidence of these infections, so we must...

An argument can be made for LASEK over LASIK for the initial laser treatment in some patients, but the re-lifting of the lasik flap and performing a laser re treatment is the management of choice in almost all cases of post lasik myopic regression. An exception would be if the cornea is too thin or...

Refractive surgery is taken for granted by patients to "get rid of their glasses and contact lenses". They rarely consider the possibility of loss of vision.

Slt and alt have been around for a while now. Slt is a new procedure.  The article treats them equally i think some distinctions should be made. More physicians should consider slt as a first line defense against Glaucoma

    The VEGF Trap from Regeneron is a protein made up off human VEGF receptors fused to human immunoglobulin.  This compound binds VEGF, preventing VEGF from binding to its natural receptors, interrupting the angiogenic cascade.    The phase II study showed promising...

This article describes the perspective of a retinal specialist on the Avastin/Lucentis controversy.  In mid-February the National Institutes of Health announced that it would conduct a head to head trial comparing the effectiveness of Lucentis and Avastin for the treatment of wet  age...